Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
GLSI · against 285 other Healthcare companies of similar size
Ranked #234 of 286 · scores higher than 18% of peers · safety percentile 19
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)19 peers with a safety percentile of 10–19, including GLSI · Click a bar to see the companies
Mainly because of its beta and current ratio, which are weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | GLSI | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 257 reported | Not reported | 0.20× | — | — | 33% |
| BetaLower is better · 271 reported | 1.46 | 0.51 | 13% | 33% | |
| Current ratioHigher is better · 282 reported | 1.54× | 3.07× | 26% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 186M USD | 100 | 52 | |
| 2 | 421M USD | 99 | 52 | |
| 3 | 165M USD | 99 | 50 | |
| 4 | 261M USD | 99 | 97 | |
| 5 | 397M USD | 99 | 37 | |
| 230 | 460M SGD (≈$350M) | 23 | 46 | |
| 231 | 3.1B CNY (≈$434M) | 22 | 35 | |
| 232 | 37.6B JPY (≈$256M) | 21 | 58 | |
| 233 | 62.7B JPY (≈$426M) | 20 | 40 | |
| 234 | 234M USD | 19 | ||
| 235 | 318M USD | 19 | 26 | |
| 236 | 454M AUD (≈$299M) | 19 | 7 | |
| 237 | 200M USD | 19 | 30 | |
| 238 | 172.4B KRW (≈$124M) | 18 | 26 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score